Just by conveying genetic information, you can have genome-edited mice at your fingertips.
We will create genome-edited mice tailored to your research. - You will receive genome-edited mice simply by providing genetic information. - We will confirm the transmission of the mutated gene to the next generation through F1 mouse production. - You can use the CRISPR/Cas9 license confidently for research purposes within the country. - Even if you are not familiar with genome editing, we will provide comprehensive technical support.
Inquire About This Product
basic information
We are conducting base deletions, exon deletions, long-chain knock-ins (1.5kb or more), ultra-long-chain knock-ins, point mutations, and the creation of flox mice. If you provide us with genetic information and mouse strains, Setrotech will handle everything from target design to the production and transplantation of genome-edited fertilized eggs, confirmation of genome editing in offspring, and the creation of F1 mice through breeding.
Price information
For more details, please contact us or download the PDF to view it.
Delivery Time
Applications/Examples of results
For more details, please contact us.
Company information
Setsuro Tech Inc. is a biotech startup that originated from Tokushima University and was founded in 2017. The company's mission is to “create an industry that solves problems for both you and the planet by harnessing the potential power of living organisms”. In 2015, Tatsuya Takemoto (Chairman & CTO) and his team at the University of Tokushima developed a method for easily and efficiently producing genome-edited mice (JP 6980218). In addition, Shun Sawatsubashi (CSO) and his team at the University of Tokushima developed the VIKING method for high-efficiency genome editing in cultured cells (JP 6956995). Additionally, Setsuro Tech Inc. has developed its own proprietary RNA-guided nuclease, ST9.5 (JP 7662138). Our company provides innovative genome editing technology and contributes to the further development of the industry, people's health, and wellbeing. We use proprietary technologies to offer contract genome editing services to researchers in academia and industry. Our goal is to provide genome-edited organisms to a wide range of industries and to advance the genome editing industry.
![[Analysis Case] Visualization of the Distribution of Components in Biomaterials](https://image.mono.ipros.com/public/product/image/506/2000253736/IPROS35437503500889400023.png?w=280&h=280)
